53 reports of this reaction
2.2% of all CEFPROZIL reports
#8 most reported adverse reaction
PYREXIA is the #8 most commonly reported adverse reaction for CEFPROZIL, manufactured by Ascend Laboratories, LLC. There are 53 FDA adverse event reports linking CEFPROZIL to PYREXIA. This represents approximately 2.2% of all 2,368 adverse event reports for this drug.
Patients taking CEFPROZIL who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PYREXIA is a less commonly reported adverse event for CEFPROZIL, but still significant enough to appear in the safety profile.
In addition to pyrexia, the following adverse reactions have been reported for CEFPROZIL:
The following drugs have also been linked to pyrexia in FDA adverse event reports:
PYREXIA has been reported as an adverse event in 53 FDA reports for CEFPROZIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PYREXIA accounts for approximately 2.2% of all adverse event reports for CEFPROZIL, making it a notable side effect.
If you experience pyrexia while taking CEFPROZIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.